Skip to content

Staphylococcus Aureus Bacteraemia (SAB)-Support-Study

SAB-Support-Study: Can Checklist-based Phone Calls Improve the Quality of Staphylococcus Aureus Bacteraemia (SAB) Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06249451
Acronym
SABOT
Enrollment
124
Registered
2024-02-08
Start date
2024-01-22
Completion date
2025-01-18
Last updated
2025-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Staphylococcus Aureus Bacteremia

Keywords

Staphylococcus aureus, Bacteremia

Brief summary

The main objective of this study is to investigate whether checklist-based close telephone consultation and process surveillance for S. aureus bacteraemia (SAB) can improve adherence to our in-house SAB-guidelines (prospective quality- improvement group). In addition, the effects of telephone consultation on the clinical outcome of patients will be examined.

Interventions

OTHERChecklist-based phone calls

The treating doctor will be called on day 1 and 12 after SAB diagnosis to point out the standard of care (as per our evidence-based in-hospital standard operating procedure (SOP)) for SAB. On day 2 and 6 after SAB diagnosis, there will be additional phone calls if clinical management does not follow hospital guidelines. The study team will also leave comments in the medical charts of the respective patients if the management does not follow hospital guidelines.

Sponsors

University Medicine Greifswald
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years * Inpatient treatment at the University Medicine Greifswald university hospital * First diagnosis of SAB in hospital

Exclusion criteria

* SAB already known before admission * Palliative management within 48 hrs after SAB diagnosis * Death within 48 hrs after SAB diagnosis * Hospital discharge within 48hrs after SAB diagnosis

Design outcomes

Primary

MeasureTime frameDescription
SOP adherence, calculated as a sum score per patient with the following 8 parameters:Hospital admission until hospital discharge (no later than day 90 after diagnosis)1. Drawing of follow-up blood cultures 2-3 days after start of adequate antibiotic therapy 2. Early source control (removal of infected material or drainage of an abscess ≤ 72 hrs) 3. Adequate search for SAB focus and metastatic manifestations 4. TEE in patients with clinical indications (within 4 days of SAB diagnosis) 5. Early start of specific therapy after receipt of results via phone call (≤12 hrs) 6. Adequate dosage of antibiotic 7. Sufficient duration of therapy (at least 14 d for uncomplicated bacteremia and 28 d for complicated bacteremia) 8. Combination therapy with Rifampicin or Fosfomycin, when indicated

Secondary

MeasureTime frame
90-day all-cause mortalityDay of SAB diagnosis until day 90 after diagnosis
90-day mortality because of SAB complicationsDay of SAB diagnosis until day 90 after diagnosis
Relapse of bacteremia until day 90 after diagnosisDay of SAB diagnosis until day 90 after diagnosis
Time to specific antimicrobial treatment according to guidelines concerning agent and durationHospital admission until hospital discharge (no later than day 90 after diagnosis)
Time to negativity of follow up blood culturesDay of SAB diagnosis until hospital discharge (no later than day 90 after diagnosis)
Time till TEE is performed (when indicated)Hospital admission until hospital discharge (no later than day 90 after diagnosis)
Length of hospital stay after SAB diagnosisDay of SAB diagnosis until hospital discharge (no later than day 90 after diagnosis)
Hospital readmission until day 90 after SAB diagnosis (because of SAB complications)Day of SAB diagnosis until day 90 after diagnosis
In-hospital mortality (because of SAB complications)Hospital admission until hospital discharge (no later than day 90 after diagnosis)
Hospital readmission until day 30 after SAB diagnosis (all patients)Day of SAB diagnosis until day 30 after diagnosis
Hospital readmission until day 30 after SAB diagnosis (because of SAB complications)Day of SAB diagnosis until day 30 after diagnosis
Hospital readmission until day 90 after SAB diagnosis (all patients)Day of SAB diagnosis until day 90 after diagnosis
Quality of discharge summary (documentation and treatment plan), calculated as a sum scoreHospital admission until hospital discharge (no later than day 90 after diagnosis)
Infectious diseases consultation, when indicated (yes/no)Hospital admission until hospital discharge (no later than day 90 after diagnosis)
In-hospital mortality (all patients)Hospital admission until hospital discharge (no later than day 90 after diagnosis)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026